A share price of ClearPoint Neuro Inc [CLPT] is currently trading at $13.56, down -1.88%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The CLPT shares have gain 3.43% over the last week, with a monthly amount drifted -4.57%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Stifel started tracking the stock with Buy rating on October 24, 2023, and set its price target to $8. Lake Street initiated its recommendation with a Buy and recommended $32 as its price target on March 18, 2021. B. Riley FBR started tracking with a Buy rating for this stock on July 17, 2020, and assigned it a price target of $8.
ClearPoint Neuro Inc experienced fluctuations in its stock price throughout the past year between $9.76 and $30.10. Currently, Wall Street analysts expect the stock to reach $18 within the next 12 months. ClearPoint Neuro Inc [NASDAQ: CLPT] shares were valued at $13.56 at the most recent close of the market. An investor can expect a potential return of 32.74% based on the average CLPT price forecast.
Analyzing the CLPT fundamentals
Trailing Twelve Months sales for ClearPoint Neuro Inc [NASDAQ:CLPT] were 34.33M which represents 9.10% growth. Gross Profit Margin for this corporation currently stands at 0.6% with Operating Profit Margin at -0.67%, Pretax Profit Margin comes in at -0.66%, and Net Profit Margin reading is -0.66%. To continue investigating profitability, this company’s Return on Assets is posted at -0.35, Equity is -0.94 and Total Capital is -0.41. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.33.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 13.06 points at the first support level, and at 12.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 14.47, and for the 2nd resistance point, it is at 15.38.
Ratios To Look Out For
To put it in perspective, the Current Ratio for ClearPoint Neuro Inc [NASDAQ:CLPT] is 6.37. Also, the Quick Ratio is 5.56, while the Cash Ratio stands at 5.62. Considering the valuation of this stock, the price to sales ratio is 11.75, the price to book ratio is 24.28.
Transactions by insiders
Recent insider trading involved PTC Therapeutics, Inc., Affiliate of director, that happened on Nov 12 ’25 when 0.89 million shares were purchased. CEO and President, BURNETT JOSEPH completed a deal on Oct 10 ’25 to sell 26463.0 shares. Meanwhile, Affiliate of Director JOSEPH M BURNETT TRUST bought 26463.0 shares on Oct 10 ’25.
